2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Normal circulatory function is a key determinant of disease-free life expectancy (healthspan).
Indeed, pathologies affecting the cardiovascular system, which are growing in prevalence …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Background Future trends in disease burden and drivers of health are of great interest to
policy makers and the public at large. This information can be used for policy and long-term …

Executive summary Stroke is the second leading cause of death worldwide. The burden of
disability after a stroke is also large, and is increasing at a faster pace in low-income and …

Chronic kidney disease (CKD) affects over 850 million people globally, and there is an
urgent need to prevent its development and progression. During the last decade, new …

Background: Single-pill combination improves adherence and persistence to medication in
hypertension. It remains unclear whether this also reduces cardiovascular outcomes and all …

Although cardiovascular diseases (CVDs) are the leading cause of death worldwide, their
pharmacotherapy remains suboptimal. Thus, there is a clear unmet need to develop more …

Aging is associated with an increasing burden of morbidity, especially for cardiovascular
diseases (CVDs). General cardiovascular risk factors, ischemic heart diseases, heart failure …